Clinical Trial Update: MDD POC Study GSK372475 Subjects Depressive Disease [Phase 2]

View source ↗

Summary

Phase 2 trial update for GSK372475 in depressive disorder shows completed status with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Depressive Disorder

Drugs mentioned

• GSK372475

Snippet

Sponsor: GlaxoSmithKline | Conditions: Depressive Disorder | Phase 2 | Status: COMPLETED | Results posted: 2018-02-05